PHOSPHONIC DIESTER DERIVATIVES
    11.
    发明申请
    PHOSPHONIC DIESTER DERIVATIVES 审中-公开
    磷酸钙衍生物

    公开(公告)号:WO99055713A1

    公开(公告)日:1999-11-04

    申请号:PCT/JP1999/002114

    申请日:1999-04-21

    CPC classification number: C07F9/650958 C07F9/4006 C07F9/4065 C07F9/588

    Abstract: Novel phosphonic diester derivatives represented by general formula (1) or pharmacologically acceptable salts thereof which are useful as drugs, wherein R represents amino, N-(lower alkyl)amino, N-(lower alkenyl)amino, etc.; R and R represent each hydrogen, lower alkyl, halogeno, lower alkoxy etc.; R represents hydrogen, lower alkyl or phenyl(lower alkyl); R and R represent each lower alkyl; X, Y and Z are all carbon atoms, or one of X, Y and Z is a nitrogen atom while other two are carbon atoms; and Q represents a single bond or alkylene.

    Abstract translation: 用作药物的通式(1)表示的新型膦酸二酯衍生物或其药理学上可接受的盐,其中R 1表示氨基,N-(低级烷基)氨基,N-(低级链烯基)氨基等; R 2和R 3各自代表氢,低级烷基,卤代,低级烷氧基等; R 4代表氢,低级烷基或苯基(低级烷基); R 5和R 6代表每个低级烷基; X,Y和Z都是碳原子,或者X,Y和Z中的一个是氮原子,而另外两个是碳原子; Q表示单键或亚烷基。

    NOVEL MIXED BENZENE ACID DERIVATIVES, METHOD FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
    14.
    发明申请
    NOVEL MIXED BENZENE ACID DERIVATIVES, METHOD FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME 审中-公开
    新型混合苯甲酸衍生物,其制备方法及其含有的药物组合物

    公开(公告)号:WO98031689A1

    公开(公告)日:1998-07-23

    申请号:PCT/FR1998/000090

    申请日:1998-01-19

    Abstract: The invention concerns a compound of formula (I) in which: R1, R2, R'1, R'2, identical or different, represent a hydrogen, halogen atom, an alkyl, alkoxy, hydroxy, nitro or trihalogenomethyl group, or R1 and R2 (respectively R'1 and R'2) form together with the benzene nucleus which bears them a naphthyl or anthracenyl group; X represents C=T, SO2, CH2, or X-A1-X represents the group (a) in which T represents an oxygen atom or a sulphur atom; A1 represents any one of the groups as defined in the description; A2, A3, identical or different, represent an alkylene group or a single bond; R3, R4, identical or different, represent any one of the groups as defined in the description. The invention also concerns its isomers as well as its additive salts to a pharmaceutically acceptable base. The invention is useful for the preparation of medicines.

    Abstract translation: 本发明涉及式(I)化合物,其中:R 1,R 2,R 1,R'2相同或不同,表示氢,卤素原子,烷基,烷氧基,羟基,硝基或三卤代甲基,或R 1 和R2(分别为R'1和R'2)与带有萘基或蒽基的苯核一起形成; X表示C = T,SO 2,CH 2或X-Al-X表示其中T表示氧原子或硫原子的基团(a); A1表示说明书中定义的任何组; A2,A3相同或不同,表示亚烷基或单键; R3,R4相同或不同,表示说明书中定义的任何一个基团。 本发明还涉及其异构体以及其与药学上可接受的碱的添加盐。 本发明可用于制备药物。

    抗がん剤組成物
    18.
    发明申请
    抗がん剤組成物 审中-公开
    抗癌药物组合物

    公开(公告)号:WO2012176823A1

    公开(公告)日:2012-12-27

    申请号:PCT/JP2012/065787

    申请日:2012-06-20

    Inventor: 中對 一博

    CPC classification number: A61K47/40 A61K31/675 C07F9/5004 C07F9/650994

    Abstract: 溶解性に優れ、高い抗がん活性を有しつつ、毒性の低い抗がん剤姿勢物が提供される。 下記一般式(1)で表されるホスフィン遷移金属錯体と、シクロデキストリン化合物とを含有することを特徴とする抗がん剤組成物。(式中、R 1 及びR 2 は、直鎖状若しくは分岐鎖状のアルキル基、シクロアルキル基、置換基を有するシクロアルキル基、アダマンチル基、フェニル基又は置換基を有するフェニル基を示し、炭素数が1~10であり、同一の基であっても異なる基であってもよい。R 3 及びR 4 は、水素原子又は直鎖状若しくは分岐鎖状のアルキル基を示し、炭素数が1~6であり、同一の基であっても異なる基であってもよい。R 3 及びR 4 は、互いに結合して飽和又は不飽和の環を形成していてもよく、該飽和又は不飽和の環は、置換基を有していてもよい。Mは、金、銅及び銀の群から選ばれる遷移金属原子を示す。X - は、アニオンを示す。)

    Abstract translation: 本发明提供一种具有优异溶解性,抗癌活性高,抗毒性低的抗癌剂组合物。 一种抗癌组合物,其特征在于含有环糊精化合物和由通式(1)表示的膦过渡金属络合物。 (式中,R 1,R 2表示直链状或支链状的烷基,环烷基,具有取代基的环烷基,金刚烷基,苯基或具有取代基的苯基,碳数为1〜 R 3和R 4可以表示相同的基团或不同的基团,R 3和R 4可以表示相同的基团或不同的基团,R 3和R 4可以表示相同的基团或不同的基团,R3和R4表示氢原子或直链或支链烷基, 通过彼此结合形成饱和或不饱和环,所述饱和或不饱和环可以具有取代基,M表示选自金,铜和银的过渡金属原子,X-表示阴离子。

    NOVEL ANTIMICROBIALS
    19.
    发明申请

    公开(公告)号:WO2009116090A3

    公开(公告)日:2009-09-24

    申请号:PCT/IN2009/000184

    申请日:2009-03-17

    Abstract: The present invention relates to novel phenyl oxazolidinone compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of Formula I and methods of treating or preventing conditions caused by microbial infections. The compounds of the present invention are effective against a number of aerobic and/or anaerobic Gram positive and/or Gram negative pathogens such as multi drug resistant Staphylococcus spp., Streptococcus spp., Enterococcus spp., Bacterioides spp., Clostridia spp., H. influenza , Moraxella Spp., as well as acid-fast organisms such as Mycobacterium tuberculosis and the like.

Patent Agency Ranking